Stock Scorer

Pediatrix Medical Group, Inc. (MD) · Insider trading

What Pediatrix Medical Group's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$1.83M
4 insiders, 0% under a plan
Net, 12 months
−$1.83M
bought less sold
Latest filing
2026-09-14
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $553,388 sold 2025-01 2025-07 2025-11: $457,494 sold 2025-12: $515,430 sold 2026-01 2026-05: $855,665 sold 2026-07
Bought Sold Largest month: $855,665

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Ordan Mark SDirector, Chief Executive Officer – $939,090 2 2025-12-15 302,805
Weis Shirley ADirector – $855,665 1 2026-05-13 –
Rucker Michael A.Director – $240,994 1 2025-11-17 59,101
Linynsky Laura ADirector – $216,500 1 2025-11-06 32,232
Moore Mary Ann EEVP, GC, Chief Admin Off & Sec – $129,728 1 2024-11-08 135,810

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-05-13 Weis Shirley ADirector Saleindirect 36,028 23.75 $855,665 0 Form 4
2025-12-15 Ordan Mark SDirector, Chief Executive Officer Sale 23,000 22.41 $515,430 302,805 Form 4
2025-11-17 Rucker Michael A.Director Sale 10,478 23.00 $240,994 59,101 Form 4
2025-11-06 Linynsky Laura ADirector Sale 10,000 21.65 $216,500 32,232 Form 4
2024-11-13 Ordan Mark SDirector Sale 27,600 15.35 $423,660 138,683 Form 4
2024-11-08 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Sale 8,108 16.00 $129,728 135,810 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

35 × grant or award11 × gift11 × shares withheld for tax3 × returned to the company
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-10 Linynsky Laura ADirector Returned to the company D −6,000 26.82 33,900 Form 4
2026-08-14 Young Sylvia JeanDirector Returned to the company D −18,500 26.62 29,786 Form 4
2026-08-12 Sansone Guy PDirector Grant or award A +472 26.50 87,416 Form 4
2026-08-12 Young Sylvia JeanDirector Grant or award A +472 26.50 48,286 Form 4
2026-08-12 Rucker Michael A.Director Grant or award A +472 26.50 66,769 Form 4
2026-08-12 Linynsky Laura ADirector Grant or award A +472 26.50 39,900 Form 4
2026-08-12 Newman Kurt DouglasDirector Grant or award A +472 26.50 17,405 Form 4
2026-08-12 Starcher John M. Jr.Director Grant or award A +472 26.50 73,732 Form 4
2026-08-12 Weis Shirley ADirector Grant or award A +472 26.50 19,095 Form 4
2026-08-12 McEachin ThomasDirector Grant or award A +472 26.50 7,668 Form 4
2026-06-22 Haddock DavidEVP, GC & Corp Sec Grant or award A +20,036 – 20,036 Form 4
2026-06-09 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Gift G −18,407 – 78,059 Form 4
2026-06-09 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Gift G +18,407 – 111,831 Form 4
2026-06-02 Ordan Mark SDirector, Chief Executive Officer Returned to the company D −97,174 – 313,710 Form 4
2026-06-02 Ordan Mark SDirector, Chief Executive Officer Grant or award A +97,174 – 410,884 Form 4
2026-06-01 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Shares withheld for tax F −11,944 21.54 96,466 Form 4
2026-06-01 Neeb Don GregoryEVP, Chief Invest & Strategy Grant or award A +63,888 – 145,234 Form 4
2026-06-01 Neeb Don GregoryEVP, Chief Invest & Strategy Shares withheld for tax F −8,003 21.54 137,231 Form 4
2026-06-01 Ordan Mark SDirector, Chief Executive Officer Grant or award A +127,198 – 430,003 Form 4
2026-06-01 Ordan Mark SDirector, Chief Executive Officer Shares withheld for tax F −19,119 21.54 410,884 Form 4
2026-06-01 Rossi Kasandra HEVP, CFO and Treasurer Grant or award A +31,800 – 105,100 Form 4
2026-06-01 Rossi Kasandra HEVP, CFO and Treasurer Shares withheld for tax F −3,701 21.54 101,399 Form 4
2026-05-13 McEachin ThomasDirector Gift G −11,427 – 7,196 Form 4
2026-05-13 McEachin ThomasDirector Gift G +11,427 – 66,073 Form 4
2026-05-11 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Gift G −40,826 – 108,410 Form 4
2026-05-07 Newman Kurt DouglasDirector Grant or award A +7,196 – 16,933 Form 4
2026-05-07 McEachin ThomasDirector Grant or award A +7,196 – 18,623 Form 4
2026-05-07 Weis Shirley ADirector Grant or award A +7,196 – 18,623 Form 4
2026-05-07 Starcher John M. Jr.Director Grant or award A +7,196 – 73,260 Form 4
2026-05-07 Young Sylvia JeanDirector Grant or award A +7,196 – 47,814 Form 4
2026-05-07 Sansone Guy PDirector Grant or award A +7,196 – 86,944 Form 4
2026-05-07 Linynsky Laura ADirector Grant or award A +7,196 – 39,428 Form 4
2026-05-07 Rucker Michael A.Director Grant or award A +7,196 – 66,297 Form 4
2026-03-01 Rossi Kasandra HEVP, CFO and Treasurer Shares withheld for tax F −3,676 19.85 73,300 Form 4
2026-03-01 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Grant or award A +39,925 – 176,167 Form 4
2026-03-01 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Shares withheld for tax F −26,931 19.85 149,236 Form 4
2025-08-20 McEachin ThomasDirector Gift G −625 – 11,427 Form 4
2025-08-19 McEachin ThomasDirector Gift G −54,021 – 12,052 Form 4
2025-08-01 Newman Kurt DouglasDirector Grant or award A +9,737 – 9,737 Form 4
2025-08-01 Neeb Don GregoryEVP, Chief Invest & Strategy Grant or award A +81,346 – 81,346 Form 4
2025-06-10 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Gift G −10,371 – 136,242 Form 4
2025-06-01 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Grant or award A +53,004 – 153,342 Form 4
2025-06-01 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Shares withheld for tax F −6,729 14.15 146,613 Form 4
2025-06-01 Ordan Mark SDirector, Chief Executive Officer Grant or award A +194,347 – 325,805 Form 4
2025-06-01 Rossi Kasandra HEVP, CFO and Treasurer Grant or award A +26,502 – 77,653 Form 4
2025-06-01 Rossi Kasandra HEVP, CFO and Treasurer Shares withheld for tax F −677 14.15 76,976 Form 4
2025-05-23 Weis Shirley ADirector Gift G −18,360 – 11,427 Form 4
2025-05-09 Ordan Mark SDirector, Chief Executive Officer Shares withheld for tax F −7,225 14.44 131,458 Form 4
2025-05-08 Starcher John M. Jr.Director Grant or award A +11,427 – 66,064 Form 4
2025-05-08 Sansone Guy PDirector Grant or award A +11,427 – 79,748 Form 4
2025-05-08 Weis Shirley ADirector Grant or award A +11,427 – 29,787 Form 4
2025-05-08 Rucker Michael A.Director Grant or award A +11,427 – 69,579 Form 4
2025-05-08 McEachin ThomasDirector Grant or award A +11,427 – 66,073 Form 4
2025-05-08 Linynsky Laura ADirector Grant or award A +11,427 – 42,232 Form 4
2025-05-08 Young Sylvia JeanDirector Grant or award A +11,427 – 40,618 Form 4
2025-03-06 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Gift G −26,497 – 100,338 Form 4
2025-03-01 Rossi Kasandra HEVP, CFO and Treasurer Shares withheld for tax F −3,718 14.77 51,151 Form 4
2025-03-01 Moore Mary Ann EEVP, GC, Chief Admin Off & Sec Shares withheld for tax F −8,975 14.77 126,835 Form 4
2025-02-25 Weis Shirley ADirector Gift G −17,668 – 18,360 Form 4
2024-12-01 Rossi Kasandra HEVP, CFO and Treasurer Grant or award A +11,112 – 54,869 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Pediatrix Medical Group's scores and multiples ›